Multiple Myeloma Cells Resistant to T-cell Therapies Exhibit a CD45+ Immunoevasive Phenotype

Alana L. Keller, Kady A. Dennis, Denis J. Ohlstrom, Sarah E. Parzych, Zachary J. Walker, Amanda J. Novak, Catherine Pham-Danis, Tanisha N. Medha, Jeremy T. Rahkola, Meher P. Boorgula, M. Eric Kohler, Daniel W. Sherbenou

Open source

DOI
10.1158/2326-6066.cir-25-1068
Published
2026-06-10
Container
Cancer Immunology Research
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/2326-6066.cir-25-1068,
  title = {Multiple Myeloma Cells Resistant to T-cell Therapies Exhibit a CD45+ Immunoevasive Phenotype},
  author = {Alana L. Keller and Kady A. Dennis and Denis J. Ohlstrom and Sarah E. Parzych and Zachary J. Walker and Amanda J. Novak and Catherine Pham-Danis and Tanisha N. Medha and Jeremy T. Rahkola and Meher P. Boorgula and M. Eric Kohler and Daniel W. Sherbenou},
  year = {2026},
  journal = {Cancer Immunology Research},
  doi = {10.1158/2326-6066.cir-25-1068},
  url = {https://doi.org/10.1158/2326-6066.cir-25-1068}
}

RIS

TY  - JOUR
TI  - Multiple Myeloma Cells Resistant to T-cell Therapies Exhibit a CD45+ Immunoevasive Phenotype
AU  - Alana L. Keller
AU  - Kady A. Dennis
AU  - Denis J. Ohlstrom
AU  - Sarah E. Parzych
AU  - Zachary J. Walker
AU  - Amanda J. Novak
AU  - Catherine Pham-Danis
AU  - Tanisha N. Medha
AU  - Jeremy T. Rahkola
AU  - Meher P. Boorgula
AU  - M. Eric Kohler
AU  - Daniel W. Sherbenou
PY  - 2026
JO  - Cancer Immunology Research
DO  - 10.1158/2326-6066.cir-25-1068
UR  - https://doi.org/10.1158/2326-6066.cir-25-1068
ER  - 

APA

Keller, A. L., Dennis, K. A., Ohlstrom, D. J., Parzych, S. E., Walker, Z. J., Novak, A. J., Pham-Danis, C., Medha, T. N., Rahkola, J. T., Boorgula, M. P., Kohler, M. E., & Sherbenou, D. W. (2026). Multiple Myeloma Cells Resistant to T-cell Therapies Exhibit a CD45+ Immunoevasive Phenotype. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-25-1068

Source records